Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.36, $0.13 better than the analyst estimate of $5.23. Revenue for the quarter came in at $10.85 billion versus the consensus estimate of $10.68 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.